The discriminative ability of the 12-item Short Form Health Survey (SF-12) in a sample of persons infected with HIVDELATE, Thomas; COONS, Stephen Joel.Clinical therapeutics. 2000, Vol 22, Num 9, pp 1112-1120, issn 0149-2918Article

Outcomes Associated With Combined Antiplatelet and Anticoagulant therapyJOHNSON, Samuel G; ROGERS, Kristina; DELATE, Thomas et al.Chest. 2008, Vol 133, Num 4, pp 948-954, issn 0012-3692, 7 p.Article

Clinical Outcomes Associated with Brand-to-Generic Phenytoin InterchangeKINIKAR, Shilpa A; DELATE, Thomas; MINDY MENAKER-WIENER, C et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 5, pp 650-658, issn 1060-0280, 9 p.Article

Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002DELATE, Thomas; GELENBERG, Alan J; SIMMONS, Valarie A et al.Psychiatric services (Washington, D.C.). 2004, Vol 55, Num 4, pp 387-391, issn 1075-2730, 5 p.Article

Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract BleedingWITT, Daniel M; DELATE, Thomas; GARCIA, David A et al.Archives of internal medicine (1960). 2012, Vol 172, Num 19, pp 1484-1491, issn 0003-9926, 8 p.Article

Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancyCLARK, Nathan P; DELATE, Thomas; CLEARY, Steven J et al.Thrombosis research. 2010, Vol 125, Num 5, pp 402-405, issn 0049-3848, 4 p.Article

Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery diseaseMERENICH, John A; OLSON, Kari L; DELATE, Thomas et al.Pharmacotherapy. 2007, Vol 27, Num 10, pp 1370-1378, issn 0277-0008, 9 p.Article

Validity of Eight Integrated Healthcare Delivery Organizations¹ Administrative Clinical Data to Capture Breast Cancer Chemotherapy ExposureDELATE, Thomas; AIELLO BOWLES, Erin J; ONITILO, Adedayo A et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 4, pp 673-680, issn 1055-9965, 8 p.Article

Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management serviceJOHNSON, Samuel G; WITT, Daniel M; EDDY, Todd R et al.Chest. 2007, Vol 131, Num 5, pp 1500-1507, issn 0012-3692, 8 p.Article

KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community SettingsWEBSTER, Jennifer; KAUFFMAN, Tia L; DAIDA, Yihe et al.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 1, pp 91-101, issn 1055-9965, 11 p.Article

A Randomized Controlled Trial of Empiric Warfarin Dose Reduction with the Initiation of Doxycycline TherapyDOWD, Mary Beth; KIPPES, Kellie A; WITT, Daniel M et al.Thrombosis research. 2012, Vol 130, Num 2, pp 152-156, issn 0049-3848, 5 p.Article

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort StudyAIELLO BOWLES, Erin J; WELLMAN, Robert; HABEL, Laurel A et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 17, pp 1293-1305, issn 0027-8874, 13 p.Article

Pilot Study of a Novel Patient Self-Management Program for Warfarin Therapy Using Venipuncture-Acquired International Normalized Ratio MonitoringSIMMONS, Brandon J; JENNER, Kathleen M; DELATE, Thomas et al.Pharmacotherapy. 2012, Vol 32, Num 12, pp 1078-1084, issn 0277-0008, 7 p.Article

Clinical Outcomes of a Home-Based Medication Reconciliation Program After Discharge from a Skilled Nursing FacilityDELATE, Thomas; CHESTER, Elizabeth A; STUBBINGS, Troy W et al.Pharmacotherapy. 2008, Vol 28, Num 4, pp 444-452, issn 0277-0008, 9 p.Article